Viewing Study NCT04681118


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2025-12-26 @ 3:50 AM
Study NCT ID: NCT04681118
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-04-23
First Post: 2020-12-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS
Sponsor: Brainstorm-Cell Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module